BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haber MM, Hunt B, Freston JW, Peura DA, Kovacs TO, Atkinson S, Hisada M. Changes of gastric histology in patients with erosive oesophagitis receiving long-term lansoprazole maintenance therapy: Gastric histology and long-term lansoprazole use. Alimentary Pharmacology & Therapeutics 2010;32:83-96. [DOI: 10.1111/j.1365-2036.2010.04310.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Dabholkar AH, Han C, Paris MM, Perez MC, Atkinson SN, Peura DA. The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease: Twelve-month safety of dexlansoprazole MR in patients with GERD. Alimentary Pharmacology & Therapeutics 2011;33:366-77. [DOI: 10.1111/j.1365-2036.2010.04519.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
2 Brunner G, Athmann C, Schneider A. Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease. Aliment Pharmacol Ther. 2012;36:37-47. [PMID: 22531114 DOI: 10.1111/j.1365-2036.2012.05106.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
3 Speck O, Appelman HD, Owens SR. Mid- and Deep-Zone Gastritis. American Journal of Clinical Pathology 2018;150:364-74. [DOI: 10.1093/ajcp/aqy065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kwak HW, Choi IJ, Cho SJ, Lee JY, Kim CG, Kook MC, Ryu KW, Kim YW. Characteristics of gastric cancer according to Helicobacter pylori infection status. J Gastroenterol Hepatol. 2014;29:1671-1677. [PMID: 24730518 DOI: 10.1111/jgh.12605] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
5 Kachuei V, Talebi Bezmin Abadi A, Rahimi F, Forootan M. Colonization by Pseudomonas aeruginosa and Staphylococcus aureus of Antral Biopsy Specimens from Gastritis Patients Uninfected with Helicobacter Pylori. Infect Drug Resist 2020;13:1411-7. [PMID: 32494172 DOI: 10.2147/IDR.S254967] [Reference Citation Analysis]
6 Muszyński J, Ziółkowski B, Kotarski P, Niegowski A, Górnicka B, Bogdańska M, Ehrmann-Jóśko A, Zemlak M, Młynarczyk-Bonikowska B, Siemińska J. Gastritis - facts and doubts. Prz Gastroenterol 2016;11:286-95. [PMID: 28053685 DOI: 10.5114/pg.2016.57793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Cockburn AN, Morgan CJ, Genta RM. Neuroendocrine Proliferations of the Stomach: A Pragmatic Approach for the Perplexed Pathologist. Advances in Anatomic Pathology 2013;20:148-57. [DOI: 10.1097/pap.0b013e31828d185d] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
8 Nordenstedt H, Graham DY, Kramer JR, Rugge M, Verstovsek G, Fitzgerald S, Alsarraj A, Shaib Y, Velez ME, Abraham N, Anand B, Cole R, El-Serag HB. Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol 2013;108:65-71. [PMID: 23147524 DOI: 10.1038/ajg.2012.372] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]